HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Print Friendly, PDF & Email

NCT/Study#

NA /

CPX351/VYXEOS

Phase IB/II Of CPX-351 As Maintenance Therapy In AML Patients Ineligible For Bone Marrow Transplantation

DISEASE GROUP:
Leukemia
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: